Baxter International Inc. (BAX) News
Filter BAX News Items
BAX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BAX News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BAX News From Around the Web
Below are the latest news stories about BAXTER INTERNATIONAL INC that investors may wish to consider to help them evaluate BAX as an investment opportunity.
Should We Be Cautious About Baxter International Inc.'s (NYSE:BAX) ROE Of 1.6%?While some investors are already well versed in financial metrics (hat tip), this article is for those who would like... |
Baxter International Inc. (BAX): Among the Biggest Dividend Cuts and Suspensions of 2024We recently compiled a list of the 10 Biggest Dividend Cuts and Suspensions of 2024. In this article, we are going to take a look at where Baxter International Inc. (NYSE:BAX) stands against the other stocks. Dividends hold great appeal for investors—they appreciate receiving them and strongly dislike reductions. Despite this, numerous major companies have reduced […] |
Baxter to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDEERFIELD, Ill., December 18, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. |
Baxter Stock May Gain Following Five New Injectable Product LaunchesBAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment. |
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.DEERFIELD, Ill., December 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024. |
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately. |
Should You Hold Baxter International (BAX) for the Long Term?Broyhill Asset Management, an investment advisor, released a third-quarter 2024, investor letter. A copy of the letter can be downloaded here. Broyhill Partners appreciated 6% net of all fees and expenses in the third quarter. The top contributors in the quarter were Philip Morris, Fiserv, Avantor, and Baxter. There was only one material detractor: Dollar […] |
New Strong Sell Stocks for November 29thBALY, BAX and CENTA have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2024. |
New Strong Sell Stocks for November 21stBATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024. |
Baxter to Present at 7th Annual Evercore HealthCONx ConferenceDEERFIELD, Ill., November 19, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:10 a.m. Eastern Time. |